Secretory processing of the Alzheimer amyloid beta/A4 protein precursor is increased by protein phosphorylation

Biochem Biophys Res Commun. 1992 Sep 30;187(3):1285-90. doi: 10.1016/0006-291x(92)90442-n.

Abstract

The 39-43 residue polypeptide (amyloid beta protein, beta A4) deposited as amyloid in Alzheimer's disease (AD) is derived from a set of 695-770 residue precursors referred to as the amyloid beta A4 protein precursor (beta APP). In each of the 695, 751, and 770 residue precursors, the 43 residue beta A4 is an internal peptide that begins 99 residues from the COOH-terminus of the beta APP. Each holoform is normally cleaved within the beta A4 to produce a large secreted derivative as well as a small membrane associated fragment. Neither of these derivatives can produce amyloid because neither contains the entire beta A4 peptide. In this study, we employ cells stably transfected with full length beta APP695, beta APP751, or beta APP770 expression constructs to show that phorbol ester activation of protein kinase C substantially increases the production of secreted forms from each isoform. By increasing processing of beta APP in the secretory pathway, PKC phosphorylation may help to prevent amyloid deposition.

MeSH terms

  • Amyloid / metabolism
  • Amyloid beta-Protein Precursor / metabolism*
  • Cells, Cultured
  • Enzyme Activation
  • Humans
  • In Vitro Techniques
  • Phorbol 12,13-Dibutyrate / pharmacology
  • Phosphoproteins / metabolism*
  • Phosphorylation
  • Protein Kinase C / metabolism
  • Protein Processing, Post-Translational
  • Recombinant Proteins / metabolism
  • Secretory Rate / drug effects
  • Transfection

Substances

  • Amyloid
  • Amyloid beta-Protein Precursor
  • Phosphoproteins
  • Recombinant Proteins
  • Phorbol 12,13-Dibutyrate
  • Protein Kinase C